India · Delayed Price · Currency is INR Aarti Drugs Company Description
Aarti Drugs Limited, through its subsidiaries, engages in the manufacture and marketing of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally.
The company offers aceclofenac, celecoxib, diclofenac sodium, diclodenac potassium, diclofenac diethylamine, diclofenac resinate, diclofenac epolamine, nimesulide, ciprofloxacin HCL, enrofloxacin base, gatifloxacin sesquihydrate, levofloxacin base, norfloxacin, ofloxacin, metronidazole, metronidazole benzoate, ornidazole, secnidazole, tinidazole, clopidogrel bisulphate, ticlopidine HCL, metformin HCL, pioglitazone HCL, teneligliptin, vildagliptin, fluconazole, ketoconazole, tolnaftate, zolpidem tartrate, niacin, raloxifene HCL, and acamprosate.
It also provides benzenesulphonyl chloride, benzenesulphonic acid, methyl benzenesulfonate, sodium benzene sulfinate, para toluene sulphonyl chloride, methyl para toluenesulfonate, sodium para toluenesulfinate, para chlorobenzenesulfonyl chloride, formamide, calcium fluoride, potasium formate, benzenesulfonamide, ethyl p- toluenesulfonate, N,N',N'-tris-(4-toluene sulfonyl)-diethylenetriamine, ortho para toluene sulfonamides, ortho para toluene sulfonamides acid methyl ester, para chlorobenznesulfonamide, para toluenesulfonyl hydrazide, para toluenesulfonamide, and sodium benzenesulfonate.
In addition, it offers pharma intermediate products, which includes Celecoxib, Ciprofloxacin, Clopidogrel, Diclofenac, Ketoconazole, Nimesulide, Raloxifene, Tinidazole, and Zolpidem.
Further, the company develops drugs for antifungal, cardiovascular, and antidiabetic therapeutic areas, as well as non-steroidal anti-inflammatory drugs.
The company was incorporated in 1984 and is headquartered in Mumbai, India.
| Country | India |
| Founded | 1984 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,355 |
| CEO | Prakash Patil |
Contact Details
Address: Mahendra Industrial Estate Mumbai, Maharashtra 400 022 India | |
| Phone | 91 22 2401 9025 |
| Website | aartidrugs.co.in |
Stock Details
| Ticker Symbol | AARTIDRUGS |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE767A01016 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Rashesh Chandrakant Gogri | MD and Chairman |
| Harshit Manila Savla | Joint MD and Executive Director |
| Adhish Prakash Patil | MD and Chief Operating Officer |
| Harit Pragji Shah | Whole-Time Director |
| Dhanaji L. Kakade | Vice President of Technical |
| Rushikesh Vivek Deole | Company Secretary and Compliance Officer |
| Arun Moreshwar Patil | Vice President of Marketing |
| Vishwa Harshit Savla | Managing Director of the Pinnacle Life Science Private Limited |
| Nilesh Bhalchandra Patil | Whole-Time Director |